Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral N-acetylcysteine for prevention of post-embolization syndrome
TCTR20240924006Phase 3Recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in post-embolization syndrome (PES), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Aug 2024; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
post-embolization syndrome (PES)
Beyond the preview
Go deeper on TCTR20240924006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240924006.